Vaxcyte (PCVX) Amortizatization of Intangibles (2021 - 2026)
Vaxcyte's (PCVX) quarterly Amortizatization of Intangibles came in at $3.1 million in Q1 2026, down 36.66% year-on-year from $4.9 million in Q1 2025, and up 12.59% on a QoQ basis from $2.8 million in Q4 2025.
Vaxcyte (PCVX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 6 years of Amortizatization of Intangibles data on file, last reported at $3.1 million in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 36.66% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $12.6 million, a 61.28% decrease from a year earlier, with the FY2025 full-year figure at $14.4 million, down 62.71% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $3.1 million, up from $2.8 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for PCVX reached as high as $14.6 million in Q3 2023 and fell as low as -$321000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $5.4 million across 5 years, with a median of $4.5 million in 2025.
- Across the five-year window, Amortizatization of Intangibles sank 112.58% in 2022 and soared 8268.28% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.2 million in 2022, then surged by 101.62% to $2.4 million in 2023, then soared by 392.87% to $11.7 million in 2024, then slumped by 76.33% to $2.8 million in 2025, then climbed by 12.59% to $3.1 million in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $3.1 million in Q1 2026, $2.8 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Vaxcyte | 7.64 Bn | 7.64 Bn | - | 3.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Mar 31, 2024 | 10.99 Mn |
| Mar 31, 2024 | 10.99 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Dec 31, 2023 | 2.37 Mn |